Choose your language
By Peptide Source Book
Cognitive peptides and sleep peptides — Semax, DSIP and Epitalon — by the evidence: what is preclinical, what is in trials, and the July 2026 FDA vote.
Healing peptides like BPC-157, TB-500 and KPV, by the evidence: what is animal-level, what is in trials, and what the July 2026 FDA vote changes.
Longevity peptides like Epitalon and MOTS-c, by the evidence: what is preclinical, what is in trials, and what the July 2026 FDA vote changes.
The FDA peptide meeting in July 2026, explained: the seven peptides up for 503A compounding, what a yes vote would change, and the one myth to ignore.
How Peptide Source Book grades peptide evidence: the six levels, where the data comes from (PubMed, ClinicalTrials.gov), and why a human RCT beats animal data.
Is BPC-157 legal? The sourced 2026 answer: US unapproved-drug and compounding status, no EU authorization, and the WADA S0 ban, clearly explained.
Newsletter
One email a week — the best comparisons, rankings and guides. No fluff.